News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

China-Biotics, Inc. to Report Fiscal Year 2011 Third Quarter Financial Results on February 9



1/31/2011 7:44:50 AM

SHANGHAI, Jan. 31, 2011 /PRNewswire-Asia-FirstCall/ --China-Biotics, Inc. ("China-Biotics", the "Company") (Nasdaq: CHBT), the leading developer, manufacturer and distributor of probiotics products in China, today announced it will host a conference call at 08:00 a.m. Eastern Time/09:00 p.m. Beijing Time on Wednesday, February 9, 2011, to discuss the fiscal year 2011 third quarter financial results for the period ended December 31, 2010.

The telephone numbers for the conference call are (866) 788-0539 (U.S.) or (857) 350-1677 (International), passcode: 68499662. A live web cast of the call will also be available on the investor relations section of the Company's website www.chn-biotics.com. To listen to the web cast, please visit the site at least 10 minutes early to register, download and install any necessary audio software.

The replay of the web cast will be archived on the website, and investors will be able to access the recording of the conference call until midnight ET on February 16, 2011 by calling (888) 286-8010 (U.S.) or (617) 801-6888 (International) and entering passcode: 95179753.

About China-Biotics

China-Biotics, Inc. ("China-Biotics" or "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements in China. Through its wholly owned subsidiaries, Shanghai Shining Biotechnology Co., Ltd. and Growing Bioengineering (Shanghai) Co. Ltd., the Company develops and produces a proprietary product portfolio. Currently, its retail products are sold over the counter, mainly through large distributors, to pharmacies and supermarkets in Beijing, Shanghai, and Jiangsu and Zhejiang provinces. The Company also sells bulk products to institutional customers such as dairy and animal feed producers as well as pharmaceutical companies. In February 2010, China-Biotics began its commercial production in China's largest probiotics production facility to meet the growing demand in China. For more information, please visit http://www.chn-biotics.com.

Contact:


Travis Cai

Chief Financial Officer

China-Biotics, Inc.

traviscai@chn-biotics.com


Shiwei Yin/Dixon Chen

Grayling

+1-646-284-9474

shiwei.yin@grayling.com

dixon.chen@grayling.com



SOURCE China-Biotics, Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES